Experts
 Menu

Colin Hill

Institution

University College Cork

Contact

Subjects

Microbiology

Details
Publications 279
As first author 3
As last author 126
Unique topics 1008
Collaborations 110
Patents 11
Sources 10
Are you Colin Hill? Click here to provide feedback on your profile.
All
2015
2014
2013
2012
2011
2010
2009
2008
2007
Earlier
All
2015
2014
2013
2012
2011
2010
2009
2008
2007
Earlier

2015

A Bioengineered Nisin Derivative to Control Biofilms of Staphylococcus pseudintermedius
2015

Antimicrobial antagonists against food pathogens; a bacteriocin perspective
2015

Bioengineering of the model lantibiotic nisin.
2015

Biotechnological applications of functional metagenomics in the food and pharmaceutical industries.
2015

Characterisation of the antibacterial properties of a bacterial derived peptidoglycan hydrolase (LysCs4), active against C. sakazakii and other Gram-negative food-related pathogens.
2015

Efficacies of Nisin A and Nisin V Semipurified Preparations Alone and in Combination with Plant Essential Oils for Controlling Listeria monocytogenes.
2015

Efficacy of nisin A and nisin V semi-purified preparations alone and in combination with plant essential oils to control Listeria monocytogenes
2015

Impact of environmental factors on bacteriocin promoter activity in gut-derived Lactobacillus salivarius.
2015

In silico identification of bacteriocin gene clusters in the gastrointestinal tract, based on the Human Microbiome Project's reference genome database.
2015

Lantibiotic Resistance.
2015

Nisin H is a new nisin variant produced by the gut-derived strain Streptococcus hyointestinalis DPC6484.
2015

The sactibiotic subclass of bacteriocins: an update.
2014

A Bioengineered Nisin Derivative to Control Biofilms of Staphylococcus pseudintermedius.
2014

A review of the systematic review process and its applicability for use in evaluating evidence for health claims on probiotic foods in the European Union.
2014

Atypical Listeria innocua strains possess an intact LIPI-3
2014

Bacterial bile salt hydrolase in host metabolism: Potential for influencing gastrointestinal microbe-host crosstalk.
2014

Combined metagenomic and phenomic approaches identify a novel salt tolerance gene from the human gut microbiome.
2014

Divergent evolution of the activity and regulation of the glutamate decarboxylase systems in Listeria monocytogenes EGD-e and 10403S: roles in virulence and acid tolerance.
2014

Exopolysaccharide-producing probiotic Lactobacilli reduce serum cholesterol and modify enteric microbiota in ApoE-deficient mice.
2014

Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic.
2014

Exploiting gut bacteriophages for human health.
2014

Fermented beverages with health-promoting potential: Past and future perspectives
2014

Genome analysis of the staphylococcal temperate phage DW2 and functional studies on the endolysin and tail hydrolase.
2014

Heterologous expression of thuricin CD immunity genes in Listeria monocytogenes.
2014

Investigation of the Antimicrobial Activity of Bacillus licheniformis Strains Isolated from Retail Powdered Infant Milk Formulae.
2014

Metagenomic identification of a novel salt tolerance gene from the human gut microbiome which encodes a membrane protein with homology to a brp/blh-family β-carotene 15,15'-monooxygenase.
2014

Proteomics as the final step in the functional metagenomics study of antimicrobial resistance.
2014

Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut.
2014

The potential for emerging therapeutic options for Clostridium difficile infection.
2013

A single point mutation in the listerial betL σ (A) -dependent promoter leads to improved osmo- and chill-tolerance and a morphological shift at elevated osmolarity.
2013

Acid stress management by Cronobacter sakazakii.
2013

Altered FXR signalling is associated with bile acid dysmetabolism in short bowel syndrome-associated liver disease.
2013

Analysis of anti-Clostridium difficile activity of thuricin CD, vancomycin, metronidazole, ramoplanin, and actagardine, both singly and in paired combinations.
2013

Atypical Listeria innocua strains possess an intact LIPI-3.
2013

Bactofencin A, a New Type of Cationic Bacteriocin with Unusual Immunity
2013

Bioavailability of the anti-clostridial bacteriocin thuricin CD in gastrointestinal tract.
2013

Detection of Mycobacterium avium subspecies paratuberculosis in patients with Crohn's disease is unrelated to the presence of single nucleotide polymorphisms rs2241880 (ATG16L1) and rs10045431 (IL12B).
2013

Functional environmental screening of a metagenomic library identifies stlA; a unique salt tolerance locus from the human gut microbiome.
2013

Gut solutions to a gut problem: bacteriocins, probiotics and bacteriophage for control of Clostridium difficile infection.
2013

In vivo activity of Nisin A and Nisin V against Listeria monocytogenes in mice
2013

Intensive Mutagenesis of the Nisin Hinge Leads to the Rational Design of Enhanced Derivatives
2013

Investigation of the use of a cocktail of lux-tagged cronobacter strains for monitoring growth in infant milk formulae.
2013

Listeria monocytogenes: survival and adaptation in the gastrointestinal tract.
2013

Metagenomics and novel gene discovery: promise and potential for novel therapeutics.
2013

Saturation Mutagenesis of Lysine 12 Leads to the Identification of Derivatives of Nisin A with Enhanced Antimicrobial Activity
2013

Selection for loss of RpoS in Cronobacter sakazakii by growing in the presence of acetate as carbon source.
2013

Sequence-based analysis of the bacterial and fungal compositions of multiple kombucha (tea fungus) samples.
2013

Sequence-based analysis of the microbial composition of water kefir from multiple sources.
2013

Sequencing-Based Analysis of the Bacterial and Fungal Composition of Kefir Grains and Milks from Multiple Sources
2013

Strategies to improve the bacteriocin protection provided by lactic acid bacteria
2013

Structure-Activity Relationship of Synthetic Variants of the Milk-Derived Antimicrobial Peptide αs2-Casein f(183-207).
2013

The Effect of Dietary Supplementation with Spent Cider Yeast on the Swine Distal Gut Microbiome
2013

The two peptide lantibiotic lacticin 3147 acts synergistically with polymyxin to inhibit Gram negative bacteria
2013

Two-tiered biological containment strategy for Lactococcus lactis-based vaccine or immunotherapy vectors.
2012

'Bac' to the future: bioengineering lantibiotics for designer purposes.
2012

A mutant in the Listeria monocytogenes Fur-regulated virulence locus (frvA) induces cellular immunity and confers protection against listeriosis in mice.
2012

A putative p-type ATPase required for virulence andresistance to haem toxicity in Listeria monocytogenes
2012

Assessing the contributions of the LiaS histidine kinase to the innate resistance of Listeria monocytogenes to nisin, cephalosporins, and disinfectants.
2012

Bacteriocins - a viable alternative to antibiotics?
2012

Bacteriophages phi MR299-2 and phi NH-4 can eliminate Pseudomonas aeruginosa in the murine Lung and on Cystic Fibrosis lung airway cells
2012

Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells.
2012

Bioengineered Nisin A Derivatives with Enhanced Activity against Both Gram Positive and Gram Negative Pathogens
2012

Bioengineered nisin derivatives with enhanced activity in complex matrices.
2012

Carriage of Clostridium difficile in outpatients with irritable bowel syndrome.
2012

Cronobacter spp. in powdered infant formula.
2012

Extensive manipulation of caseicins A and B highlights the tolerance of these antimicrobial peptides to change.
2012

Functional metagenomics reveals novel salt tolerance loci from the human gut microbiome.
2012

Gut microbiota composition correlates with diet and health in the elderly.
2012

HmgR, a key enzyme in the mevalonate pathway for isoprenoid biosynthesis, is essential for growth of Listeria monocytogenes EGDe.
2012

In vivo activity of nisin A and nisin V against Listeria monocytogenes in mice.
2012

Insights into Lantibiotic Immunity Provided by Bioengineering of LtnI.
2012

Isolation and characterization of bacteriocin-producing bacteria from the intestinal microbiota of elderly Irish subjects.
2012

Isoprenoid biosynthesis in bacterial pathogens.
2012

Mining the human gut microbiome for novel stress resistance genes.
2012

Movers and shakers: Influence of bacteriophages in shaping the mammalian gut microbiota.
2012

Polymorphisms in rpoS and stress tolerance heterogeneity in natural isolates of Cronobacter sakazakii.
2012

Probiotics in transition.
2012

Production of bioactive substances by intestinal bacteria as a basis for explaining probiotic mechanisms: Bacteriocins and conjugated linoleic acid
2012

Production of the antimicrobial peptides Caseicin A and B by Bacillus isolates growing on sodium caseinate.
2012

Saturation mutagenesis of lysine 12 leads to the identification of derivatives of nisin A with enhanced antimicrobial activity.
2012

Saturation mutagenesis of selected residues of the α-peptide of the lantibiotic lacticin 3147 yields a derivative with enhanced antimicrobial activity.
2012

Strategies to improve the bacteriocin protection provided by lactic acid bacteria.
2012

Subspecies diversity in bacteriocin production by intestinal Lactobacillus salivarius strains
2012

Survival of Mycobacterium avium subsp. paratuberculosis in synthetic human gastric juice and acidified porcine bile.
2012

The impact of antibiotics on the gut microbiota as revealed by high throughput DNA sequencing.
2012

Virulence or niche factors: what's in a name?
2011

A putative P-type ATPase required for virulence and resistance to haem toxicity in Listeria monocytogenes.
2011

A role for proline synthesis and transport in Listeria monocytogenes barotolerance.
2011

Altering the composition of caseicins A and B as a means of determining the contribution of specific residues to antimicrobial activity.
2011

Bacteriocin production: a probiotic trait?
2011

Clostridium difficile carriage in elderly subjects and associated changes in the intestinal microbiota.
2011

E. coli O104:H4: social media and the characterization of an emerging pathogen.
2011

Factors affecting survival of Listeria monocytogenes and Listeria innocua in soil samples.
2011

Fate and efficacy of lacticin 3147-producing Lactococcus lactis in the mammalian gastrointestinal tract.
2011

Genome mining for radical SAM protein determinants reveals multiple sactibiotic-like gene clusters
2011

High-throughput sequence-based analysis of the bacterial composition of kefir and an associated kefir grain.
2011

Homologues and bioengineered derivatives of LtnJ vary in ability to form D-alanine in the lantibiotic lacticin 3147.
2011

Host Specific Diversity in Lactobacillus johnsonii as Evidenced by a Major Chromosomal Inversion and Phage Resistance Mechanisms
2011

Human neutrophil clearance of bacterial pathogens triggers anti-microbial γδ T cell responses in early infection
2011

Identification and characterization of an essential gene in Listeria monocytogenes using an inducible gene expression system.
2011

Impact of the broad-spectrum antimicrobial peptide, lacticin 3147, on Streptococcus mutans growing in a biofilm and in human saliva.
2011

Inhibitory activity of Lactobacillus plantarum LMG P-26358 against Listeria innocua when used as an adjunct starter in the manufacture of cheese
2011

Investigation of the role of ZurR in the physiology and pathogenesis of Listeria monocytogenes.
2011

Lantibiotic production by pathogenic microorganisms.
2011

Novel listerial genetic loci conferring enhanced barotolerance in Escherichia coli.
2011

Production of bioactive substances by intestinal bacteria as a basis for explaining probiotic mechanisms: bacteriocins and conjugated linoleic acid.
2011

Production of multiple bacteriocins from a single locus by gastrointestinal strains of Lactobacillus salivarius
2011

Real-time monitoring of luciferase-tagged Cronobacter sakazakii in reconstituted infant milk formula.
2011

Salmonella spp. survival strategies within the host gastrointestinal tract.
2011

Streptolysin S-like virulence factors: the continuing sagA.
2011

The Lantibiotic Lacticin 3147 Prevents Systemic Spread of Staphylococcus aureus in a Murine Infection Model.
2011

The impact of nisin on sensitive and resistant mutants of Listeria monocytogenes in cottage cheese.
2011

The spiFEG locus in Streptococcus infantarius subsp. infantarius BAA-102 confers protection against nisin U.
2010

A five-gene stress survival islet (SSI-1) that contributes to the growth of Listeria monocytogenes in suboptimal conditions.
2010

Bioengineering of a Nisin A-producing Lactococcus lactis to create isogenic strains producing the natural variants Nisin F, Q and Z.
2010

Directed evolution and targeted mutagenesis to murinize Listeria monocytogenes internalin A for enhanced infectivity in the murine oral infection model.
2010

Effect of bioengineering lacticin 3147 lanthionine bridges on specific activity and resistance to heat and proteases.
2010

Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon.
2010

Food safety: What can we learn from genomics?
2010

Glutamate decarboxylase-mediated nisin resistance in Listeria monocytogenes.
2010

Host specific diversity in Lactobacillus johnsonii as evidenced by a major chromosomal inversion and phage resistance mechanisms.
2010

In silico analysis highlights the frequency and diversity of type 1 lantibiotic gene clusters in genome sequenced bacteria
2010

Investigating the importance of charged residues in lantibiotics.
2010

Investigation of the mechanisms by which Listeria monocytogenes grows in porcine gallbladder bile.
2010

Lacticin 3147--biosynthesis, molecular analysis, immunity, bioengineering and applications.
2010

Real-time PCR assay to differentiate Listeriolysin S-positive and -negative strains of Listeria monocytogenes.
2010

Studies with bioengineered Nisin peptides highlight the broad-spectrum potency of Nisin V.
2010

Synthesis of trypsin-resistant variants of the Listeria-active bacteriocin salivaricin P
2010

TelA contributes to the innate resistance of Listeria monocytogenes to nisin and other cell wall-acting antibiotics.
2010

The ABC transporter AnrAB contributes to the innate resistance of Listeria monocytogenes to nisin, bacitracin, and various beta-lactam antibiotics.
2010

The dawning of a 'Golden era' in lantibiotic bioengineering.
2010

The impact of iron on Listeria monocytogenes; inside and outside the host.
2010

Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile.
2009

A comparison of the activities of lacticin 3147 and nisin against drug-resistant Staphylococcus aureus and Enterococcus species.
2009

Administration of a live culture of Lactococcus lactis DPC 3147 into the bovine mammary gland stimulates the local host immune response, particularly IL-1beta and IL-8 gene expression
2009

Administration of a live culture of Lactococcus lactis DPC 3147 into the bovine mammary gland stimulates the local host immune response, particularly IL-1β and IL-8 gene expression
2009

AgrD-dependent quorum sensing affects biofilm formation, invasion, virulence and global gene expression profiles in Listeria monocytogenes.
2009

Carnitine enhances the growth of Listeria monocytogenes in infant formula at 7 degrees C.
2009

Cross-immunity and immune mimicry as mechanisms of resistance to the lantibiotic lacticin 3147.
2009

Discovery of medically significant lantibiotics.
2009

Efficacy of a teat dip containing the bacteriocin lacticin 3147 to eliminate Gram-positive pathogens associated with bovine mastitis
2009

Evaluation of an antimicrobial ingredient prepared from a Lactobacillus acidophilus casein fermentate against Enterobacter sakazakii.
2009

Evaluation of colostrum-derived human mammary-associated serum amyloid A3 (M-SAA3) protein and peptide derivatives for the prevention of enteric infection: in vitro and in murine models of intestinal disease.
2009

Exposure to bile influences biofilm formation by Listeria monocytogenes
2009

Identification of a novel two-peptide lantibiotic, lichenicidin, following rational genome mining for LanM proteins.
2009

Manipulation of charged residues within the two-peptide lantibiotic lacticin 3147.
2009

Molecular characterization of the arginine deiminase system in Listeria monocytogenes: regulation and role in acid tolerance.
2009

Penicillin-binding proteins (PBP) and Lmo0441 (a PBP-like protein) play a role in beta-lactam sensitivity of Listeria monocytogenes
2009

Probiotics and gastrointestinal disease: successes, problems and future prospects.
2009

Probiotics and pharmabiotics: alternative medicine or an evidence-based alternative?
2009

Production of the Bsa lantibiotic by community-acquired Staphylococcus aureus strains.
2009

Rational design of improved pharmabiotics.
2009

Specific osmolyte transporters mediate bile tolerance in Listeria monocytogenes.
2009

The interaction between Listeria monocytogenes and the host gastrointestinal tract.
2009

The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission.
2009

Understanding the mechanisms by which probiotics inhibit gastrointestinal pathogens.
2008

Analysis of the isoprenoid biosynthesis pathways in Listeria monocytogenes reveals a role for the alternative 2-C-methyl-D-erythritol 4-phosphate pathway in murine infection.
2008

Antimicrobial activity of two peptides casecidin 15 and 17, found naturally in bovine colostrum.
2008

Characterization of enterocin- and salivaricin-producing lactic acid bacteria from the mammalian gastrointestinal tract.
2008

Development of a luciferase-based reporter system to monitor Bifidobacterium breve UCC2003 persistence in mice
2008

Development of multiple strain competitive index assays for Listeria monocytogenes using pIMC; a new site-specific integrative vector
2008

Engineered pharmabiotics with improved therapeutic potential.
2008

Enhancing bile tolerance improves survival and persistence of Bifidobacterium and Lactococcus in the murine gastrointestinal tract
2008

Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome.
2008

High-pressure processing--effects on microbial food safety and food quality.
2008

Intramammary infusion of a live culture of Lactococcus lactis for treatment of bovine mastitis: comparison with antibiotic treatment in field trials
2008

Isolation and analysis of bacteria with antimicrobial activities from the marine sponge Haliclona simulans collected from Irish waters.
2008

Lantibiotic immunity.
2008

Listeriolysin S, a Novel Peptide Haemolysin Associated with a Subset of Lineage I Listeria monocytogenes
2008

Metagenomics.
2008

Molecular analysis of the microbial food safety implications of food reformulations for improved health.
2008

The generation of nisin variants with enhanced activity against specific gram-positive pathogens.
2008

The presence of pMRC01 promotes greater cell permeability and autolysis in lactococcal starter cultures.
2008

Tools for functional postgenomic analysis of listeria monocytogenes.
2007

'Bioengineered Bugs' - a patho-biotechnology approach to probiotic research and applications.
2007

A novel promoter trap identifies Listeria monocytogenes promoters expressed at a low pH within the macrophage phagosome.
2007

A significant role for Sigma B in the detergent stress response of Listeria monocytogenes.
2007

A system for the random mutagenesis of the two-peptide lantibiotic lacticin 3147: analysis of mutants producing reduced antibacterial activities.
2007

Antimicrobial activity of lacticin 3,147 against clinical Clostridium difficile strains.
2007

Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118.
2007

Casein fermentate of Lactobacillus animalis DPC6134 contains a range of novel propeptide angiotensin-converting enzyme inhibitors.
2007

Construction of p16Slux, a novel vector for improved bioluminescent labeling of gram-negative bacteria.
2007

Contamination of milk by enterococci and coliforms from bovine faeces.
2007

Controlling Listeria monocytogenes in Cottage cheese through heterologous production of enterocin A by Lactococcus lactis.
2007

Fate of the two-component lantibiotic lacticin 3147 in the gastrointestinal tract.
2007

Food reformulations for improved health: A potential risk for microbial food safety?
2007

Gut osmolarity: a key environmental cue initiating the gastrointestinal phase of Listeria monocytogenes infection?
2007

Identification of a novel two-peptide lantibiotic, haloduracin, produced by the alkaliphile Bacillus halodurans C-125.
2007

Impact of selected Lactobacillus and Bifidobacterium species on Listeria monocytogenes infection and the mucosal immune response.
2007

Improved luciferase tagging system for Listeria monocytogenes allows real-time monitoring in vivo and in vitro.
2007

Improving gastric transit, gastrointestinal persistence and therapeutic efficacy of the probiotic strain Bifidobacterium breve UCC2003.
2007

Insertional mutagenesis to generate lantibiotic resistance in Lactococcus lactis.
2007

M-cells: origin, morphology and role in mucosal immunity and microbial pathogenesis.
2007

New frontiers in probiotic research.
2007

Pseudomonas aeruginosa RsmA plays an important role during murine infection by influencing colonization, virulence, persistence, and pulmonary inflammation.
2007

Relatedness between the two-component lantibiotics lacticin 3147 and staphylococcin C55 based on structure, genetics and biological activity
2007

Salivaricin P, one of a family of two-component antilisterial bacteriocins produced by intestinal isolates of Lactobacillus salivarius.
2007

The glutamate decarboxylase acid resistance mechanism affects survival of Listeria monocytogenes LO28 in modified atmosphere-packaged foods.
2007

Two-peptide lantibiotics: a medical perspective.
2006

A lacticin 3147 enriched food ingredient reduces Streptococcus mutans isolated from the human oral cavity in saliva.
2006

An in vitro cell-culture model demonstrates internalin- and hemolysin-independent translocation of Listeria monocytogenes across M cells.
2006

Casein-derived antimicrobial peptides generated by Lactobacillus acidophilus DPC6026.
2006

Complete alanine scanning of the two-component lantibiotic lacticin 3147: generating a blueprint for rational drug design.
2006

Contribution of penicillin-binding protein homologs to antibiotic resistance, cell morphology, and virulence of Listeria monocytogenes EGDe.
2006

Enterococcus and Lactobacillus contamination of raw milk in a farm dairy environment.
2006

Evaluation of live-culture-producing lacticin 3147 as a treatment for the control of Listeria monocytogenes on the surface of smear-ripened cheese.
2006

Kluyveromyces lactis and Saccharomyces cerevisiae, two potent deacidifying and volatile-sulphur-aroma-producing microorganisms of the cheese ecosystem.
2006

Novel luciferase reporter system for in vitro and organ-specific monitoring of differential gene expression in Listeria monocytogenes.
2006

Overproduction of wild-type and bioengineered derivatives of the lantibiotic lacticin 3147.
2006

Relatedness between the two-component lantibiotics lacticin 3147 and staphylococcin C55 based on structure, genetics and biological activity.
2006

Spontaneous resistance in Lactococcus lactis IL1403 to the lantibiotic lacticin 3147.
2006

Tolerance of Listeria monocytogenes to cell envelope-acting antimicrobial agents is dependent on SigB.
2006

pEOC01: a plasmid from Pediococcus acidilactici which encodes an identical streptomycin resistance (aadE) gene to that found in Campylobacter jejuni.
2005

Bacterial lantibiotics: strategies to improve therapeutic potential.
2005

Bacteriocins: developing innate immunity for food.
2005

Contribution of three bile-associated loci, bsh, pva, and btlB, to gastrointestinal persistence and bile tolerance of Listeria monocytogenes.
2005

Insertional inactivation of determinants for Mg2+ and Co2+ transport as a tool for screening recombinant Lactococcus species clones.
2005

Listeria monocytogenes PerR mutants display a small-colony phenotype, increased sensitivity to hydrogen peroxide, and significantly reduced murine virulence.
2005

Posttranslational conversion of L-serines to D-alanines is vital for optimal production and activity of the lantibiotic lacticin 3147.
2005

Presence of GadD1 glutamate decarboxylase in selected Listeria monocytogenes strains is associated with an ability to grow at low pH.
2005

Role for HtrA in stress induction and virulence potential in Listeria monocytogenes.
2005

Sequential actions of the two component peptides of the lantibiotic lacticin 3147 explain its antimicrobial activity at nanomolar concentrations.
2005

The lantibiotic lacticin 3147 produced in a milk-based medium improves the efficacy of a bismuth-based teat seal in cattle deliberately infected with Staphylococcus aureus.
2004

Controlled autolysis and enzyme release in a recombinant lactococcal strain expressing the metalloendopeptidase enterolysin A.
2004

Disruption of putative regulatory loci in Listeria monocytogenes demonstrates a significant role for Fur and PerR in virulence.
2004

Dry cow therapy with a non-antibiotic intramammary teat seal - a review
2004

High pressure-induced inactivation of Qbeta coliphage and c2 phage in oysters and in culture media.
2004

Relative ability of orally administered Lactobacillus murinus to predominate and persist in the porcine gastrointestinal tract.
2004

The interaction between bacteria and bile.
2004

The interplay between classical and alternative isoprenoid biosynthesis controls gammadelta T cell bioactivity of Listeria monocytogenes.
2004

Update on the development of a novel dry cow therapy using a bismuth-based intramammary teat seal in combination with the bacteriocin lacticin 3147
2004

Variable bacteriocin production in the commercial starter Lactococcus lactis DPC4275 is linked to the formation of the cointegrate plasmid pMRC02.
2003

A food-grade approach for functional analysis and modification of native plasmids in Lactococcus lactis.
2003

A lacticin 481-producing adjunct culture increases starter lysis while inhibiting nonstarter lactic acid bacteria proliferation during Cheddar cheese ripening.
2003

Generation of food-grade lactococcal starters which produce the lantibiotics lacticin 3147 and lacticin 481.
2003

Identification and disruption of btlA, a locus involved in bile tolerance and general stress resistance in Listeria monocytogenes.
2003

Potential of the enterocin regulatory system to control expression of heterologous genes in Enterococcus.
2003

Production of enterolysin A by a raw milk enterococcal isolate exhibiting multiple virulence factors.
2003

Surviving the acid test: responses of gram-positive bacteria to low pH.
2002

Bacterial osmoadaptation: the role of osmolytes in bacterial stress and virulence.
2002

Bile stress response in Listeria monocytogenes LO28: adaptation, cross-protection, and identification of genetic loci involved in bile resistance.
2002

Elevated enzyme release from lactococcal starter cultures on exposure to the lantibiotic lacticin 481, produced by Lactococcus lactis DPC5552.
2002

Lantibiotics produced by lactic acid bacteria: structure, function and applications.
2002

Potential of bacteriocin-producing lactic acid bacteria for improvements in food safety and quality.
2002

The LisRK signal transduction system determines the sensitivity of Listeria monocytogenes to nisin and cephalosporins.
2002

Use of lacticin 481 to facilitate delivery of the bacteriophage resistance plasmid, pCBG104 to cheese starters.
2001

A glutamate decarboxylase system protects Listeria monocytogenes in gastric fluid.
2001

Characterization of the groESL operon in Listeria monocytogenes: utilization of two reporter systems (gfp and hly) for evaluating in vivo expression.
2001

Evaluation of a spray-dried lacticin 3147 powder for the control of Listeria monocytogenes and Bacillus cereus in a range of food systems.
2001

Heterologous expression of lacticin 3147 in Enterococcus faecalis: comparison of biological activity with cytolysin.
2001

Identification and disruption of the proBA locus in Listeria monocytogenes: role of proline biosynthesis in salt tolerance and murine infection.
2001

Lantibiotics: structure, biosynthesis and mode of action.
2001

Mutations in the listerial proB gene leading to proline overproduction: effects on salt tolerance and murine infection.
2001

Naturally occurring lactococcal plasmid pAH90 links bacteriophage resistance and mobility functions to a food-grade selectable marker.
2001

Regulation of immunity to the two-component lantibiotic, lacticin 3147, by the transcriptional repressor LtnR.
2001

Role of the glutamate decarboxylase acid resistance system in the survival of Listeria monocytogenes LO28 in low pH foods.
2000

Analysis of the role of betL in contributing to the growth and survival of Listeria monocytogenes LO28.
2000

Analysis of the role of the Listeria monocytogenes F0F1 -AtPase operon in the acid tolerance response.
2000

Combination of hydrostatic pressure and lacticin 3147 causes increased killing of Staphylococcus and Listeria.
2000

Each peptide of the two-component lantibiotic lacticin 3147 requires a separate modification enzyme for activity.
2000

Efficient method for the detection of microbially-produced antibacterial substances from food systems.
2000

Identification and overexpression of ltnl, a novel gene which confers immunity to the two-component lantibiotic lacticin 3147.
2000

Novel type I restriction specificities through domain shuffling of HsdS subunits in Lactococcus lactis.
2000

Protection against Staphylococcus aureus mastitis in dairy cows using a bismuth-based teat seal containing the bacteriocin, lacticin 3147.
2000

The use of listeriolysin to identify in vivo induced genes in the gram-positive intracellular pathogen Listeria monocytogenes.
1999

Characterization and heterologous expression of the genes encoding enterocin a production, immunity, and regulation in Enterococcus faecium DPC1146.
1999

Developing applications for lactococcal bacteriocins.
1999

Extensive post-translational modification, including serine to D-alanine conversion, in the two-component lantibiotic, lacticin 3147.
1999

Identification and disruption of BetL, a secondary glycine betaine transport system linked to the salt tolerance of Listeria monocytogenes LO28.
1999

Identification and disruption of lisRK, a genetic locus encoding a two-component signal transduction system involved in stress tolerance and virulence in Listeria monocytogenes.
1999

In situ inversion of the conjugative transposon Tn916 in Enterococcus faecium DPC3675.
1999

Lacticin 3147 displays activity in buffer against gram-positive bacterial pathogens which appear insensitive in standard plate assays.
1999

The natural food grade inhibitor, lacticin 3147, reduced the incidence of mastitis after experimental challenge with Streptococcus dysgalactiae in nonlactating dairy cows.
1999

The relationship between acid stress responses and virulence in Salmonella typhimurium and Listeria monocytogenes.
1998

Evaluation of lacticin 3147 and a teat seal containing this bacteriocin for inhibition of mastitis pathogens.
1997

A mutant of Listeria monocytogenes LO28 unable to induce an acid tolerance response displays diminished virulence in a murine model.
1997

Determination of the influence of organic acids and nisin on shelf-life and microbiological safety aspects of fresh pork sausage.
1996

Acid adaptation of Listeria monocytogenes can enhance survival in acidic foods and during milk fermentation.
1996

Adaptive acid tolerance response in Listeria monocytogenes: isolation of an acid-tolerant mutant which demonstrates increased virulence.

These are the 10 unique sources for Colin Hill's 279 publications. A single publication may appear in multiple sources. Click on a name or publication count to see the publications for a particular source.

Source #
Ireland -> Maynooth University 1
Ireland -> Maynooth University -> PubMed 1
Ireland -> Teagasc 102
Ireland -> Teagasc -> PubMed 76
Ireland -> Trinity College Dublin 1
Ireland -> Trinity College Dublin -> PubMed 1
Ireland -> University College Cork 178
Ireland -> University College Cork -> PubMed 162
Ireland -> University of Limerick 1
Ireland -> University of Limerick -> PubMed 1
18-Dec-2014

BILE SALT HYDROLASE BSH1 FOR REGULATING WEIGHT GAIN, SERUM CHOLESTEROL LEVELS, AND LIVER TRIGLYCERIDES IN A MAMMAL; BACTERIA STRAINS EXPRESSING BSH1 VARIANTS
+
30-Jan-2013

Antimicrobial peptide produced by intestinal Lactobacillus salivarius
+
20-Jun-2012

Pseudomonas aeruginosa Bacteriophage and uses thereof
+
29-Jun-2011

Nisin derivatives and the use thereof
+
12-Nov-2009

NISIN DERIVATIVES AND THE USE THEREOF
+
30-Jul-2009

LISTERIA MONOCYTOGENES CYTOTOXIN LISTERIOLYSIN S
+
30-Aug-2007

ANGIOTENSIN-I-CONVERTING ENZYME INHIBITORY
+
24-May-2007

ANTIMICROBIAL PEPTIDES AND BACTERIAL STRAINS THAT PRODUCE THEM
+
02-Nov-2006

PROBIOTIC COMPOSITION SUITABLE FOR ANIMALS
+
29-Dec-1999

A SPRAY-DRIED BACTERIOCIN POWDER WITH ANTI-MICROBIAL ACTIVITY
+
29-Dec-1999

AN ANTIMICROBIAL EFFECTIVE AGAINST GRAM-POSITIVE PATHOGENS
+

  1. Further insights

    Clicking through these tabs will give you a wealth of further insights into this expert through their commonly used topics, the evolution of their expertise, their collaborators and their publications.

  2. Details

    Here is a quick breakdown of this expert's publication history

  3. Contact

    If this is the expert you have been looking for, simply click here to make contact.